Intuitive Surgical, Inc. $ISRG Shares Sold by TD Waterhouse Canada Inc.

TD Waterhouse Canada Inc. lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 25.1% during the third quarter, HoldingsChannel reports. The firm owned 14,638 shares of the medical equipment provider’s stock after selling 4,907 shares during the period. TD Waterhouse Canada Inc.’s holdings in Intuitive Surgical were worth $6,412,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of ISRG. JSF Financial LLC boosted its holdings in shares of Intuitive Surgical by 41.8% during the third quarter. JSF Financial LLC now owns 563 shares of the medical equipment provider’s stock valued at $252,000 after acquiring an additional 166 shares during the period. Chesapeake Wealth Management lifted its stake in shares of Intuitive Surgical by 1.9% in the 3rd quarter. Chesapeake Wealth Management now owns 2,461 shares of the medical equipment provider’s stock worth $1,101,000 after acquiring an additional 46 shares during the period. Traynor Capital Management Inc. lifted its holdings in shares of Intuitive Surgical by 15.8% in the third quarter. Traynor Capital Management Inc. now owns 63,880 shares of the medical equipment provider’s stock valued at $28,569,000 after buying an additional 8,730 shares during the period. Field & Main Bank lifted its stake in Intuitive Surgical by 2.8% during the third quarter. Field & Main Bank now owns 3,377 shares of the medical equipment provider’s stock valued at $1,510,000 after purchasing an additional 93 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. raised its position in shares of Intuitive Surgical by 10.5% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 254,069 shares of the medical equipment provider’s stock worth $113,627,000 after purchasing an additional 24,227 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $504.22 on Friday. The company has a market cap of $180.75 billion, a price-to-earnings ratio of 63.91, a P/E/G ratio of 3.92 and a beta of 1.67. The firm has a 50-day moving average of $558.64 and a 200-day moving average of $511.63. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same period in the prior year, the firm earned $2.21 earnings per share. The company’s revenue was up 18.8% on a year-over-year basis. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms recently weighed in on ISRG. Citigroup reissued a “neutral” rating and set a $590.00 price target (down from $635.00) on shares of Intuitive Surgical in a research report on Friday, January 23rd. Truist Financial increased their price target on shares of Intuitive Surgical from $620.00 to $650.00 and gave the company a “buy” rating in a report on Thursday, December 18th. Raymond James Financial upped their target price on shares of Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a research note on Friday, January 23rd. HSBC lifted their target price on shares of Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a research note on Monday, January 26th. Finally, Leerink Partners upped their target price on shares of Intuitive Surgical from $593.00 to $600.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $620.41.

Insider Activity

In related news, EVP Henry L. Charlton sold 13,731 shares of the stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the transaction, the executive vice president directly owned 3,056 shares of the company’s stock, valued at $1,772,480. This represents a 81.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Craig H. Barratt sold 750 shares of the business’s stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $435,000.00. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 75,683 shares of company stock valued at $42,066,425. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.